Rituximab (Rituxan) plus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) is the standard induction therapy for patients with advanced-stage diffuse large B-cell lymphoma, including both elderly and younger patients.
Jerry Ingram
Advertisement
Articles by Jerry Ingram
Advertisement
Latest Updated Articles
- R-CHOP is standard of care for advanced DLBCL patients
Published: November 1st 2007 | Updated:
